LIVE
New today 401
Updated 524
New executives 2,378
Reported capital $ 659,500
Sign up Log in

SIDGMAN PHARMA, S.A.

CORPORATION (JOINT-STOCK COMPANY) ACTIVE #97,9131,011,615 total
Total views
131
Avg / month
11
Year peak
28
Current month -33.3 % vs Dec
6

Company information

Folio
558461 Mercantil
Registration date
08/03/2007
Validity
PERPETUAL
Status
ACTIVE
Last update
20/08/2018 (hace 7 años)
Request update

Highlights SIDGMAN PHARMA, S.A.

Currency
NO-PAR VALUE SHARES
Share capital
-

Executives SIDGMAN PHARMA, S.A. (8)

Name
Role
Links
View
  • Name GILBERTO SUCRE Subscriber 130
    Role: Subscriber
    Links: 130
  • Name VERHUSKA CONTRERAS Subscriber 11
    Role: Subscriber
    Links: 11
  • Name AUGUSTO BENAVIDES MATARAZZO Director 8
    Role: Director
    Links: 8
  • Name LUIS ALBERTO AGUILERA FERNANDEZ Director 9
    Role: Director
    Links: 9
  • Name DANIELA FRANCISCA BENAVIDES CHAVEZ Director 3
    Role: Director
    Links: 3
  • Name ALEX AGUILERA GODOY Director 3
    Role: Director
    Links: 3
  • Name AUGUSTO BENAVIDES MATARAZZO President 8
    Role: President
    Links: 8
  • Name LUIS ALBERTO AGUILERA FERNANDEZ Treasurer 9
    Role: Treasurer
    Links: 9
  • Name LUIS ALBERTO AGUILERA FERNANDEZ Secretary 9
    Role: Secretary
    Links: 9
  • Name SUCRE & ASOCIADOS Resident Agent 212
    Role: Resident Agent
    Links: 212
  • Name LA EJERCERAN DE MANERA CONJUNTA EL PRESIDENTE Y EL SECRETARIO. REPRESENTATIVE - —
    Role: REPRESENTATIVE
    Links: -
    —
*Links: number of companies where the executive appears with a role or relation.

Documents SIDGMAN PHARMA, S.A. (0)

Act
Date
View
  • No documents

Entries / Precedence SIDGMAN PHARMA, S.A. (0)

Procedure / Document type
Year
View
Request deletion
About SIDGMAN PHARMA, S.A.: Summary of SIDGMAN PHARMA, S.A.: entity CORPORATION (JOINT-STOCK COMPANY), status VIGENTE. Address in Panamá. Registered since 08/03/2007. Estimated traffic: 131 total visits (peak 28). Position: #97,913 of 1,011,615. See representatives, branches, documents and filings.